Eli Lilly and Company (NEO:LLY)
Canada
· Delayed Price · Currency is CAD 34.15
+0.53 (1.58%)
Feb 28, 2025, 4:00 PM EST
Eli Lilly and Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 45,043 | 34,124 | 28,541 | 28,318 | 24,540 | Upgrade
|
| Revenue Growth (YoY) | 32.00% | 19.56% | 0.79% | 15.40% | 9.95% | Upgrade
|
| Cost of Revenue | 8,418 | 7,082 | 6,630 | 6,973 | 5,483 | Upgrade
|
| Gross Profit | 36,624 | 27,042 | 21,912 | 21,345 | 19,057 | Upgrade
|
| Selling, General & Admin | 8,132 | 6,941 | 6,068 | 6,142 | 5,869 | Upgrade
|
| Research & Development | 10,991 | 9,313 | 7,191 | 6,931 | 5,976 | Upgrade
|
| Operating Expenses | 19,123 | 16,255 | 13,258 | 13,073 | 11,846 | Upgrade
|
| Operating Income | 17,502 | 10,787 | 8,653 | 8,273 | 7,211 | Upgrade
|
| Interest Expense | -780.6 | -485.9 | -331.6 | -339.8 | -359.6 | Upgrade
|
| Interest & Investment Income | 175.2 | 173.6 | 62.8 | 25.4 | 33 | Upgrade
|
| Currency Exchange Gain (Loss) | -288.3 | -26.4 | -191.3 | -204.6 | 123.7 | Upgrade
|
| Other Non Operating Income (Expenses) | 262.9 | -6.3 | 177 | 256 | -319.2 | Upgrade
|
| EBT Excluding Unusual Items | 16,871 | 10,442 | 8,370 | 8,010 | 6,689 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -13 | -151.2 | Upgrade
|
| Gain (Loss) on Sale of Investments | -49.5 | -20.2 | -410.7 | 176.9 | 1,442 | Upgrade
|
| Legal Settlements | -435 | - | - | - | - | Upgrade
|
| Other Unusual Items | -425.6 | -67.7 | -244.6 | -1,048 | 20 | Upgrade
|
| Pretax Income | 12,680 | 6,555 | 6,806 | 6,156 | 7,230 | Upgrade
|
| Income Tax Expense | 2,090 | 1,314 | 561.6 | 573.8 | 1,036 | Upgrade
|
| Earnings From Continuing Operations | 10,590 | 5,240 | 6,245 | 5,582 | 6,194 | Upgrade
|
| Net Income | 10,590 | 5,240 | 6,245 | 5,582 | 6,194 | Upgrade
|
| Net Income to Common | 10,590 | 5,240 | 6,245 | 5,582 | 6,194 | Upgrade
|
| Net Income Growth | 102.08% | -16.08% | 11.88% | -9.88% | -25.54% | Upgrade
|
| Shares Outstanding (Basic) | 901 | 900 | 902 | 907 | 908 | Upgrade
|
| Shares Outstanding (Diluted) | 904 | 903 | 905 | 912 | 913 | Upgrade
|
| Shares Change (YoY) | 0.09% | -0.15% | -0.77% | -0.09% | -2.48% | Upgrade
|
| EPS (Basic) | 11.76 | 5.82 | 6.93 | 6.15 | 6.82 | Upgrade
|
| EPS (Diluted) | 11.71 | 5.80 | 6.90 | 6.12 | 6.79 | Upgrade
|
| EPS Growth | 101.90% | -15.94% | 12.75% | -9.87% | -23.65% | Upgrade
|
| Free Cash Flow | 3,760 | 792.5 | 5,731 | 6,056 | 5,112 | Upgrade
|
| Free Cash Flow Per Share | 4.16 | 0.88 | 6.34 | 6.64 | 5.60 | Upgrade
|
| Dividend Per Share | 5.200 | 4.520 | 3.920 | 3.400 | 2.960 | Upgrade
|
| Dividend Growth | 15.04% | 15.31% | 15.29% | 14.86% | 14.73% | Upgrade
|
| Gross Margin | 81.31% | 79.25% | 76.77% | 75.38% | 77.66% | Upgrade
|
| Operating Margin | 38.86% | 31.61% | 30.32% | 29.21% | 29.38% | Upgrade
|
| Profit Margin | 23.51% | 15.36% | 21.88% | 19.71% | 25.24% | Upgrade
|
| Free Cash Flow Margin | 8.35% | 2.32% | 20.08% | 21.39% | 20.83% | Upgrade
|
| EBITDA | 19,268 | 12,315 | 10,176 | 9,820 | 8,535 | Upgrade
|
| EBITDA Margin | 42.78% | 36.09% | 35.65% | 34.68% | 34.78% | Upgrade
|
| D&A For EBITDA | 1,767 | 1,527 | 1,523 | 1,548 | 1,324 | Upgrade
|
| EBIT | 17,502 | 10,787 | 8,653 | 8,273 | 7,211 | Upgrade
|
| EBIT Margin | 38.86% | 31.61% | 30.32% | 29.21% | 29.38% | Upgrade
|
| Effective Tax Rate | 16.49% | 20.05% | 8.25% | 9.32% | 14.33% | Upgrade
|
| Advertising Expenses | 1,440 | 1,120 | 966.8 | 1,240 | 1,100 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.